Citigroup’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Buy |
|
|||||
|
2025
Q1 | $644K | Buy |
|
|||||
|
2024
Q4 | $668K | Buy |
|
|||||
|
2024
Q3 | $273K | Buy |
|
|||||
|
2024
Q2 | $206K | Sell |
|
|||||
|
2024
Q1 | $4.99M | Buy |
|
|||||
|
2023
Q4 | $2M | Buy |
|
|||||
|
2023
Q3 | $1.6M | Buy |
|
|||||
|
2023
Q2 | $1.68M | Sell |
|
|||||
|
2023
Q1 | $7.12M | Buy |
|
|||||
|
2022
Q4 | $3.21M | Sell |
|
|||||
|
2022
Q3 | $5.76M | Buy |
|
|||||
|
2022
Q2 | $126K | Sell |
|
|||||
|
2022
Q1 | $882K | Sell |
|
|||||
|
2021
Q4 | $4.47M | Buy |
|
|||||
|
2021
Q3 | $85K | Buy |
|